Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Molecular Genetics Laboratory, |
RCV001174000 | SCV001337120 | uncertain significance | Charcot-Marie-Tooth disease | criteria provided, single submitter | clinical testing | ||
Labcorp Genetics |
RCV005093741 | SCV005833309 | likely benign | Charcot-Marie-Tooth disease axonal type 2O | 2024-10-04 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003908428 | SCV004718194 | uncertain significance | DYNC1H1-related disorder | 2024-02-13 | no assertion criteria provided | clinical testing | The DYNC1H1 c.12250A>G variant is predicted to result in the amino acid substitution p.Ile4084Val. This variant is present in the AAA6 domain, which is within the motor domain of DYNC1H1. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.00088% of alleles in individuals of European (Non-Finnish) descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |